Published: 2017-04-27

Functional status of reproductive system under treatment of silver nanoparticles in female mice

Alina P. Lytvynenko, Ludmila S. Rieznichenko, Valentine A. Sribna, Maria I. Stupchuk, Nataliya G. Grushka, Alena A. Shepel, Tetyana Yu. Voznesenska, Taras V. Blashkiv, Oksana N. Kaleynykova


Background: The use of silver nanoparticles (AgNP) has increased very significantly in recent years the work in science is currently on focused on assessing human health and environmental risks of nanotechnology. The aim of the present study was to estimate the functional status of the female reproductive system in mice under condition of the intravenous treatment of silver nanoparticles (AgNPs), namely to assess meiotic maturation of oocytes, viability of follicular cells surrounding the oocyte, spontaneous contractile activity of the myometrium and pre-and post-implantation mortality of embryos.

Methods: Research (two series) has been done on white laboratory mice (8 weeks, 16-18 g). AgNPs are spherical nanoparticles of 30 nm (8 mg/ml for metal) diluted in water for injection. Method of treatment: intravenous. Two doses (2 mg/kg and 4 mg/kg) have been investigated. Frequency of treatment: one time per day with each dose of 1, 5 and 10 times (n=10 animals in each group). Material for the study (ovaries, uterus) were taken the day after the last AgNPs injection.

Results: Ten-time AgNPs treatment (2 mg/kg and 4 mg/kg) results in inhibition of oocytes meiotic maturation in mice; a single- and five-time AgNPs treatment (2 mg/kg and 4 mg/kg) increases the number of apoptotic cells, while the ten-time AgNPs treatment results in an increase of the apoptotic and necrotic follicular cells surrounding oocytes; for the five-and ten-time AgNPs treatment (4 mg/kg) the index of contractility (IC) of the uterus increased; for the ten-time AgNPs treatment (2 mg/kg and 4 mg/kg) no differences in value of the embryonic mortality between control and study groups have been observed.

Conclusions: This study suggests that the development of nanomaterials should be safer and non-toxic and the potential reprotoxicity of AgNPs should be investigated more carefully.


Embryos, Myometrium, Oocytes, Silver nanoparticles

Full Text:



Fabrega J, Luoma S, Tyler C, Galloway T, Lead J. Silver nanoparticles: behaviour and effects in the aquatic environment. Environ Int. 2011;37(2):517-31.

Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761): 622-7.

Levard C, Hotze E, Lowry G, Brown G. Environmental transformations of silver nanoparticles: impact on stability and toxicity. Environ Sci Technol. 2012;46(13):6900-14.

Chernousova S, Epple M. Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl. 2013;52(6):1636-53.

Gullam J, Blanks A, Thornton S, Shmygol A. Phase-plot analysis of the oxytocin effect on human myometrial contractility. Eur J Obstet Gynecol Reprod Biol. 2009;144(1):20-4.

Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659-61.

Park K, Park E, Chun I, Choi K, Lee S, Yoon J, et al. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res. 2011; 34(1):153-8.

Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, Oczkowski M, Krawczyńska A, Chwastowska J, et al. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol. 2012;32(11): 920-8.

Xue Y, Zhang S, Huang Y, Zhang T, Liu X, Hu Y, et al. Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J Appl Toxicol. 2012;32(11):890-9.

De Jong W, Van Der Ven L, Sleijffers A, Park M, Jansen E, Van Loveren H, et al. Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials. 2013;34(33):8333-43.

Rigo C, Ferroni L, Tocco I, Roman M, Munivrana I, Gardin C, et al. Active silver nanoparticles for wound healing. Int J Mol Sci. 2013;14(3):4817-40.

Wei L, Lu J, Xu H, Patel A, Chen Z, Chen G. Silver nanoparticles: synthesis, properties, and therapeutic applications. Drug Discov Today. 2015;20(5):595-601.

van der Zande M, Vandebriel R, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero C, et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano. 2012;6(8):7427-42.

Kwon J, Minai-Tehrani A, Hwang S, Kim J, Shin J, Yu K, et al. Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicol Res. 2012;28(1):25-31.

Recordati C, De Maglie M, Bianchessi S, Argentiere S, Cella C, Mattiello S, et al. Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects. Part Fibre Toxicol. 2016; 29(13):12.

Johnston H, Hutchison G, Christensen F, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40(4): 328-46.

Tiedemann D, Taylor U, Rehbock C, Jakobi J, Klein S, Kues W, et al. Reprotoxicity of gold, silver, and gold-silver alloy nanoparticles on mammalian gametes. Analyst. 2014;139(5):931-42.

Taylor U, Tiedemann D, Rehbock C, Kues W, Barcikowski S, Rath D. Influence of gold, silver and gold-silver alloy nanoparticles on germ cell function and embryo development. Beilstein J Nanotechnol. 2015;5(6):651-64.

Li P, Kuo T, Chang J, Yeh J, Chan W. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett. 2010;197(2):82-7.

Taylor U, Garrels W, Barchanski A, Peterson S, Sajti L, Lucas-Hahn A, et al. Injection of ligand-free gold and silver nanoparticles into murine embryos does not impact pre-implantation development. Beilstein J Nanotechnol. 2014;21(5):677-88.

Yu W, Son J, Lee J, Kim S, Lee I, Baek H, et al. Effects of silver nanoparticles on pregnant dams and embryo-fetal development in rats. Nanotoxicology. 2014;8(1):85-91.

Durán N, Durán M, de Jesus M, Seabra A, Fávaro W, Nakazato G. Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity. Nanomedicine. 2016;12(3):789-99.

Hsin Y, Chen C, Huang S, Shih T, Lai P, Chueh P. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 2008;179(3):130-9.

Laban G, Nies L, Turco R, Bickham J, Sepúlveda M. The effects of silver nanoparticles on fathead minnow (Pimephales promelas) embryos. Ecotoxicology. 2010;19(1):185-95.

Choi J, Kim S, Ahn J, Youn P, Kang J, Park K, et al. Induction of oxidative stress and apoptosis by silver nanoparticles in the liver of adult zebrafish. Aquat Toxicol. 2010;100(2):151-9.

Maillard J, Hartemann P. Silver as an antimicrobial: facts and gaps in knowledge. Crit Rev Microbiol. 2013;39(4):373-83.